Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers

Lawrence R. Dearth, Hua Qian, Ting Wang, Timothy E. Baroni, Jue Zeng, Stephanie W. Chen, Sun Young Yi, Rainer K. Brachmann

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences